It hydrates my mature skin, too ...

Evommune (EVMN) added more than ~50% in early trading on Tuesday after the biotech announced a mid-stage trial win for EVO301 ...

To help you find the best eczema-friendly skin care products, I tapped several dermatologists for their insights and product recommendations.

The results vaulted Nektar’s market value to over $1 billion amid expectations the drug might prove a challenger to widely ...

An eczema drug from Nektar Therapeutics maintained skin responses in a one-year study, meeting and in some cases exceeding ...

It's often dismissed as just a rash, but for Amy Carr, eczema is a painful, expensive condition which controls what she can and can't do with her life. Eczema costs sufferers thousands of dollars and ...

TRex Bio banked a Series B extension to advance its atopic dermatitis program, which is competing in a crowded field.

Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people.

Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price to jump 75% in premarket trading. The biotech, which went public late last year, ...

Nektar Therapeutics (NKTR) stock jumps on positive mid-stage trial data for its experimental drug targeting atopic dermatitis. Read more here.

The decision comes more than a year after disappointing initial Phase 3 results and casts further doubt on a class of ...

Infants given acetaminophen (also called paracetamol; brand name, Tylenol) for pain or fever relief in their first year were ...